Secreted β-amyloid precursor protein activates microglia via JNK and p38-MAPK

被引:70
作者
Bodles, AM
Barger, SW [1 ]
机构
[1] Univ Arkansas Med Sci, Donald W Reynolds Dept Geriatr, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Little Rock, AR 72205 USA
[3] Cent Arkansas Vet Healthcare Syst, Geriatr Res Educ Clin Ctr, Little Rock, AR 72205 USA
关键词
Alzheimer's disease; APP; inflammation; MAP kinase; microglia; nitric oxide synthase; stress-activated kinase;
D O I
10.1016/j.neurobiolaging.2004.02.022
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Reactive microglia are thought to play a role in the pathogenesis of Alzheimer's disease (AD) and are localized to the senile plaques that are associated with cognitive decline. The beta-amyloid precursor protein (betaAPP) is over-expressed in the dystrophic neurites near such plaques, and secreted forms of betaAPP (sAPPalpha) activate inflammatory responses in microglia. To characterize the mechanisms by which sAPPalpha activates microglia, we assayed its effects on MAP kinases, including c-Jun N-terminal kinases (INK), extracellular signal-regulated protein kinases (ERK), and p38-MAPK. sAPPalpha was found to rapidly activate JNKs, ERKs and p38-MAPK in a dose-dependent manner. The JNK inhibitor SP600125 and the p38 inhibitor SB203580 independently reduced both nitrite accumulation and induction of inflammatory nitric oxide synthase (iNOS). By contrast, inhibition of the ERK pathway with U0126 did not appreciably affect either outcome measure. These findings suggest that sAPP activates the ERK, JNK and p38 classes of MAP kinases but that only JNK and p38-MAPK are critical for activation of microglia by sAPPalpha, a process that compromises neuronal function and survival. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 45 条
[1]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[2]   Non-steroidal anti-inflammatory drugs stimulate secretion of non-amyloidogenic precursor protein [J].
Avramovich, Y ;
Amit, T ;
Youdim, MBH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :31466-31473
[3]   Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E [J].
Barger, SW ;
Harmon, AD .
NATURE, 1997, 388 (6645) :878-881
[4]   Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function [J].
Barger, SW ;
Basile, AS .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (03) :846-854
[5]  
BARGER SW, 2000, NEUROIMMUNE INTERACT, P57
[6]  
Bhat NR, 1998, J NEUROSCI, V18, P1633
[7]  
Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO
[8]  
2-E
[9]   Presenilins and APP in neuritic and synaptic plasticity - Implications for the pathogenesis of Alzheimer's disease [J].
Chan, SL ;
Furukawa, K ;
Mattson, MP .
NEUROMOLECULAR MEDICINE, 2002, 2 (02) :167-196
[10]  
Chen CC, 1999, MOL PHARMACOL, V55, P481